Quanterix Corporation is developing a novel platform for single-molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research. Their unique approach permits rapid quantification and analysis of individual proteins and small molecules within complex biological samples, enabling us to address a variety of unmet medical needs. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease. Quanterix’s technology is designed to enable much earlier disease detection, better prognosis, and precise treatment methods to improve the quality of life and longevity of the population for generations to come.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Provides threat detection and screening technologies for military, transportation, homeland security and resilience applications

Part of Bruker Corp., Bruker Daltonik GmbH is a German company located in Bremen. The firm manufactures mass spectrometry systems for life sciences. Jürgen Srega, Wolfgang Pusch and Rohan Ashok Thakur are the current co-CEOs of the company.

Micromass UK Ltd. develops, manufactures and distributes analytical instruments. The firm manufactures a line of mass spectrometry products. It offers various platforms for drug discovery applications based on its technology. Mircomass is a wholly owned subsidiary of Waters Corp. The company was founded in 1996 and is headquartered in Manchester, UK.

Hewlett-Packard Development Co. is a private company headquartered in Beijing, China. The firm manufactures and supplies personal computers. Yi Liang Chen is the current CEO of the firm.

BioArray Solutions Ltd. develops and manufactures products for transfusion and transplantation medicine. Its solutions proprietary technology platform combines semiconductor technology, micro particle chemistry, and molecular biology to bring unparalleled flexibility and performance to quantitative DNA and protein analysis. The company was founded in 1997 and is headquartered in Warren, NJ.

Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio describes its platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides. The company's first commercial product, the PacBio RS, was sold to a limited set of customers in 2010 and was commercially released in early 2011. A subsequent version of the sequencer called the PacBio RS II was released in April 2013. On 25 September 2013 a partnership between Pacific Biosciences and Roche Diagnostics was announced for the development of in vitro diagnostic products using the technology, with Roche providing US$75,000,000 in the deal. In 2015, the company launched a new sequencing instrument called the Sequel System with approximately 7-fold greater capacity than the PacBio RS II. Then in April 2019 the company launched the Sequel II system with a further 8-fold increase in throughput.

NV Technology, Inc., part of Rim Semiconductor Co., is an American company located in Pleasanton, CA. The firm develops and markets digital transmission technology for Internet access and cable television services.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

Roche Diagnostics Operations, Inc. provides healthcare services. It offers commercial physical and biological research and development. The company is headquartered in Indianapolis, IN.

LECO Corporation, founded in 1936 by Carl Schultz and George Krasl, operates its analytical instrumentation research and development, and manufacturing from its headquarters located in St. Joseph, Michigan. LECO develops and manufactures elemental measurement and molecular Time-of-flight mass spectrometry instrumentation, following ISO 9000 standards. The LECO trademark is an acronym of the original name, Laboratory Equipment Corporation.

Palamedrix is a developer of a multi-omic platform designed to accelerate advancements in life science and medicine. The company utilizes DNA nanotechnology to procure solutions for biomedical applications by providing comprehensive data. Palamedrix was established in 2017 by Shane Bowen in San Diego, California.

IonSense, Inc. provides open-air mass spectrometry solutions to the fields of food safety, forensics, drug development, and chemical analysis. The firm''s products include DART, DART-QDa for Waters Acquity and QDa detector, ID-CUBE, and ASAP Probe. It manufactures and markets the DART (direct analysis in real time) ionization source. The company was founded by Douglas Simmons in 2005 and is headquartered in Saugus, MA.